hpv positive oropharyngeal squamous cell carcinoma

Showing 1 - 20 of 20

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Head Neck Cancer, Head and Neck Squamous Cell Carcinoma, Oropharynx Cancer Trial in United States (other, radiation, diagnostic

Not yet recruiting
  • Head and Neck Cancer
  • +4 more
  • Experimental Observation
  • +3 more
  • Baltimore, Maryland
  • +5 more
Oct 16, 2023

Head Neck Cancer, Cervical Cancer, Non-small Cell Carcinoma Trial in Scottsdale, Chapel Hill (TSC-204-A0201, TSC-204-C0702,

Not yet recruiting
  • Head and Neck Cancer
  • +20 more
  • TSC-204-A0201
  • +4 more
  • Scottsdale, Arizona
  • +1 more
Aug 3, 2023

Using Human Papillomavirus DNA Testing to Detect HPV-Related

Recruiting
  • Oropharyngeal Cancer
  • +2 more
  • NavDx
  • Basking Ridge, New Jersey
  • +6 more
Apr 3, 2023

Cervical Cancer, Throat Cancer, Oropharynx Cancer Trial in New Brunswick (E7 TCR-T cells)

Not yet recruiting
  • Cervical Cancer
  • +20 more
  • E7 TCR-T cells
  • New Brunswick, New Jersey
  • +1 more
Jan 18, 2023

HPV-Associated Cervical Carcinoma, HPV-Related Carcinoma, HPV-Related Malignancy Trial in New Brunswick (Conditioning, E7 TCR-T

Not yet recruiting
  • HPV-Associated Cervical Carcinoma
  • +16 more
  • Conditioning, E7 TCR-T cells, and aldesleukin
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Jan 17, 2023

Will Permit Sites to Proactively Assess TAA, HLA and HPV-16

Terminated
  • Head and Neck Cancer
  • +7 more
  • Tumor Profiling
  • Scottsdale, Arizona
  • +2 more
Dec 2, 2022

HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Orange (Intensity-Modulated Radiation Therapy (IMRT))

Recruiting
  • HPV Positive Oropharyngeal Squamous Cell Carcinoma
  • Intensity-Modulated Radiation Therapy (IMRT)
  • Orange, California
    Chao Family Comprehensive Cancer Center, University of Californi
Nov 4, 2022

Head Neck Cancer, Oropharynx Cancer, HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Columbia (Cisplatin injection)

Recruiting
  • Cancer of the Head and Neck
  • +3 more
  • Cisplatin injection
  • Columbia, Missouri
    University of Missouri
Oct 31, 2022

Squamous Cell Carcinoma of the Oropharynx, HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Carmel, Indianapolis (44

Recruiting
  • Squamous Cell Carcinoma of the Oropharynx
  • HPV Positive Oropharyngeal Squamous Cell Carcinoma
  • 44 doses of radiation
  • 54 doses of radiation
  • Carmel, Indiana
  • +1 more
Oct 5, 2022

Head Neck Cancer, Squamous Cell Carcinoma of the Head and Neck, HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in New

Completed
  • Head and Neck Cancer
  • +2 more
  • ADXS11-001 (ADXS-HPV)
  • New York, New York
  • +1 more
Sep 9, 2022

Human Papilloma Virus, HPV, HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Chicago (HB-201, HB-202, Carboplatin)

Recruiting
  • Human Papilloma Virus
  • +3 more
  • Chicago, Illinois
    University of Chicago
Aug 11, 2022

HPV-Associated Oropharyngeal Squamous Cell Carcinoma, HPV Positive Oropharyngeal Squamous Cell Carcinoma, HPV-Mediated

Recruiting
  • HPV-Associated Oropharyngeal Squamous Cell Carcinoma
  • +11 more
  • NavDx HPV ctDNA Testing
  • +2 more
  • Boston, Massachusetts
  • +1 more
Jul 6, 2022

HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in United States (Cisplatin-based Radiation Therapy, Cisplatin

Recruiting
  • HPV Positive Oropharyngeal Squamous Cell Carcinoma
  • Cisplatin-based Radiation Therapy
  • Cisplatin Chemotherapy
  • Beverly Hills, California
  • +3 more
Jul 6, 2022

HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Boston (Blood test for HPV DNA)

Recruiting
  • HPV Positive Oropharyngeal Squamous Cell Carcinoma
  • Blood test for HPV DNA
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jun 8, 2022

HPV Positive Oropharyngeal Squamous Cell Carcinoma, HIV-1-infection, HPV Infection Trial in São Paulo, Cuernavaca, San Juan (9

Recruiting
  • HPV Positive Oropharyngeal Squamous Cell Carcinoma
  • +2 more
  • 9 valent human papillomavirus vaccine (Types 6, 11, 16, 18, 31, 33, 45, 52, 58)
  • Saline Placebo
  • São Paulo, Brazil
  • +2 more
Mar 25, 2022

Solid Tumor, Microsatellite Stable Colorectal Cancer, HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Canada, Korea,

Recruiting
  • Solid Tumor
  • +8 more
  • TBio-6517
  • Pembrolizumab
  • Phoenix, Arizona
  • +10 more
Feb 21, 2022

Carcinoma, Squamous Cell of Head and Neck, HPV Positive Oropharyngeal Squamous Cell Carcinoma, Hypopharyngeal Cancer Trial in

Completed
  • Carcinoma, Squamous Cell of Head and Neck
  • +5 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 24, 2022

HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Australia, New Zealand (Cetuximab, RT (70 Gy in 35 fractions),

Active, not recruiting
  • HPV Positive Oropharyngeal Squamous Cell Carcinoma
  • Canberra, Australian Capital Territory, Australia
  • +15 more
Feb 7, 2021

Oropharyngeal Squamous Cell Carcinoma, HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial (Computed Tomography, Positron

Withdrawn
  • Oropharyngeal Squamous Cell Carcinoma
  • HPV Positive Oropharyngeal Squamous Cell Carcinoma
  • Computed Tomography
  • Positron Emission Tomography
  • (no location specified)
Aug 5, 2019